Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00136500 · ClinicalTrials.gov registry record
Clinical Research in ALS Study
A clinical trial of Amyotrophic Lateral Sclerosis, sponsored by University of Miami.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT00136500 is a study of Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by University of Miami. The registered enrollment target is 10,000 participants, above the 800-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (1150% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00136500, a study of Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
CRiALS is an umbrella protocol through which people are recruited to participate in a range of research studies being conducted by the ALS Research Collaboration (ARC).
Conditions Studied
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2005-02 |
| Est. Completion | 2037-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00136500
The ClinicalTrials.gov registry entry for NCT00136500 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 800-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (1150% higher). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT00136500 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00136500 about?
NCT00136500 is a clinical study titled "Clinical Research in ALS Study". CRiALS is an umbrella protocol through which people are recruited to participate in a range of research studies being conducted by the ALS Research Collaboration (ARC).
What is the current status of trial NCT00136500?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2005-02. Estimated completion is 2037-12.
What conditions does trial NCT00136500 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.
Who is sponsoring clinical trial NCT00136500?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00136500 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
PREVENT ALL ALS Study
RECRUITING
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.